Pages that link to "Q71560759"

The following pages link to Inhibition of human platelet functions by verapamil (Q71560759):

Displaying 12 items.

• Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction (Q24187926) (← links)
• The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon (Q34417580) (← links)
• Epinephrine at doses used in dentistry deteriorates platelet retention rate (Q36289799) (← links)
• Protective Effects of Calcium Antagonists Against Ischaemia and Reperfusion Damage (Q36691455) (← links)
• Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension (Q38679740) (← links)
• Effects of organic and inorganic Ca antagonists on rat platelet arachidonic acid metabolism in the presence of Ca2 , Sr2 and Ba2 . (Q41261085) (← links)
• Inhibition of human platelet functions by cyclandelate (Q41430497) (← links)
• Stereospecific inhibition of 5-HT-induced increase of intracellular free calcium by ( )- and (-)-desmethoxyverapamil in human platelets (Q42153826) (← links)
• The influence of cyclandelate on Ca translocation in human platelets (Q42523566) (← links)
• Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110. (Q42752561) (← links)
• Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment (Q68838884) (← links)
• Proceedings of the British Pharmacological Society 8th-10th September, 1982. Abstracts (Q70538312) (← links)